APO RESEARCH · REPORT
Scopolamine
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
Product & engineering
Understand the product.
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
Selected research
Industry Research
Scopolamine Industry Research Report 2026
Market perspective
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
Report Scope
Read the full market overview
This report quantifies the global Scopolamine market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Scopolamine Market by Company
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Scopolamine Segment by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Scopolamine Segment by Application
Tablets
Injection
Patches
Scopolamine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Scopolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Scopolamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Scopolamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Scopolamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Scopolamine Butylbromide
- Scopolamine Hydrobromide
- Others
Applications
- Tablets
- Injection
- Patches
Companies covered
- Alkaloids of Australia
- Boehringer Ingelheim
- Fine Chemicals Corporation
- Phytex Australia
- Alchem International
- Guangzhou Hanfang
- Alkaloids Corporation
- Luyin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Scopolamine Market Size (2021-2032)
- 2.2.2 Global Scopolamine Sales (2021-2032)
- 2.2.3 Global Scopolamine Market Average Price (2021-2032)
- 2.3 Scopolamine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Scopolamine Butylbromide
- 2.3.3 Scopolamine Hydrobromide
- 2.3.4 Others
- 2.4 Scopolamine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablets
- 2.4.3 Injection
- 2.4.4 Patches
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Scopolamine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Scopolamine Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Scopolamine Revenue of Manufacturers (2021-2026)
- 3.4 Global Scopolamine Average Price by Manufacturers (2021-2026)
- 3.5 Global Scopolamine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Scopolamine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Scopolamine, Product Type & Application
- 3.8 Global Manufacturers of Scopolamine, Established Date
- 3.9 Global Scopolamine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alkaloids of Australia
- 4.1.1 Alkaloids of Australia Company Information
- 4.1.2 Alkaloids of Australia Business Overview
- 4.1.3 Alkaloids of Australia Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alkaloids of Australia Scopolamine Product Portfolio
- 4.1.5 Alkaloids of Australia Recent Developments
- 4.2 Boehringer Ingelheim
- 4.2.1 Boehringer Ingelheim Company Information
- 4.2.2 Boehringer Ingelheim Business Overview
- 4.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
- 4.2.5 Boehringer Ingelheim Recent Developments
- 4.3 Fine Chemicals Corporation
- 4.3.1 Fine Chemicals Corporation Company Information
- 4.3.2 Fine Chemicals Corporation Business Overview
- 4.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
- 4.3.5 Fine Chemicals Corporation Recent Developments
- 4.4 Phytex Australia
- 4.4.1 Phytex Australia Company Information
- 4.4.2 Phytex Australia Business Overview
- 4.4.3 Phytex Australia Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Phytex Australia Scopolamine Product Portfolio
- 4.4.5 Phytex Australia Recent Developments
- 4.5 Alchem International
- 4.5.1 Alchem International Company Information
- 4.5.2 Alchem International Business Overview
- 4.5.3 Alchem International Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Alchem International Scopolamine Product Portfolio
- 4.5.5 Alchem International Recent Developments
- 4.6 Guangzhou Hanfang
- 4.6.1 Guangzhou Hanfang Company Information
- 4.6.2 Guangzhou Hanfang Business Overview
- 4.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
- 4.6.5 Guangzhou Hanfang Recent Developments
- 4.7 Alkaloids Corporation
- 4.7.1 Alkaloids Corporation Company Information
- 4.7.2 Alkaloids Corporation Business Overview
- 4.7.3 Alkaloids Corporation Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Alkaloids Corporation Scopolamine Product Portfolio
- 4.7.5 Alkaloids Corporation Recent Developments
- 4.8 Luyin
- 4.8.1 Luyin Company Information
- 4.8.2 Luyin Business Overview
- 4.8.3 Luyin Scopolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Luyin Scopolamine Product Portfolio
- 4.8.5 Luyin Recent Developments
5 Global Scopolamine Market Scenario by Region
- 5.1 Global Scopolamine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Scopolamine Sales by Region: 2021-2032
- 5.2.1 Global Scopolamine Sales by Region: 2021-2026
- 5.2.2 Global Scopolamine Sales by Region: 2027-2032
- 5.3 Global Scopolamine Revenue by Region: 2021-2032
- 5.3.1 Global Scopolamine Revenue by Region: 2021-2026
- 5.3.2 Global Scopolamine Revenue by Region: 2027-2032
- 5.4 North America Scopolamine Market Facts & Figures by Country
- 5.4.1 North America Scopolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Scopolamine Sales by Country (2021-2032)
- 5.4.3 North America Scopolamine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Scopolamine Market Facts & Figures by Country
- 5.5.1 Europe Scopolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Scopolamine Sales by Country (2021-2032)
- 5.5.3 Europe Scopolamine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Scopolamine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Scopolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Scopolamine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Scopolamine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Scopolamine Market Facts & Figures by Country
- 5.7.1 South America Scopolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Scopolamine Sales by Country (2021-2032)
- 5.7.3 South America Scopolamine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Scopolamine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Scopolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Scopolamine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Scopolamine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Scopolamine Sales by Type (2021-2032)
- 6.1.1 Global Scopolamine Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Scopolamine Sales Market Share by Type (2021-2032)
- 6.2 Global Scopolamine Revenue by Type (2021-2032)
- 6.2.1 Global Scopolamine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Scopolamine Revenue Market Share by Type (2021-2032)
- 6.3 Global Scopolamine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Scopolamine Sales by Application (2021-2032)
- 7.1.1 Global Scopolamine Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Scopolamine Sales Market Share by Application (2021-2032)
- 7.2 Global Scopolamine Revenue by Application (2021-2032)
- 7.2.1 Global Scopolamine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Scopolamine Revenue Market Share by Application (2021-2032)
- 7.3 Global Scopolamine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Scopolamine Value Chain Analysis
- 8.1.1 Scopolamine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Scopolamine Production Mode & Process
- 8.2 Scopolamine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Scopolamine Distributors
- 8.2.3 Scopolamine Customers
9 Global Scopolamine Analyzing Market Dynamics
- 9.1 Scopolamine Industry Trends
- 9.2 Scopolamine Industry Drivers
- 9.3 Scopolamine Industry Opportunities and Challenges
- 9.4 Scopolamine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst